Notice of Closed Meeting, 16001-16002 [2022-05802]

Download as PDF Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices During the evaluation of offers on a construction contract, the contracting officer reviews the offeror’s PLA to determine if it conforms with all statutes, regulations, and Executive Orders. • FAR 52.222–34, Project Labor Agreement. When a PLA is required for a construction contract, this clause requires the contractor to maintain the PLA in a current state throughout the life of the contract. This recordkeeping requirement is necessary for the Government to ensure that the contractor stays a party to the PLA during the life of the construction contract. • FAR 52.222–46, Evaluation of Compensation for Professional Employees. This provision requires offerors to submit for evaluation a total compensation plan setting forth proposed salaries and fringe benefits for professional employees working on the contract. The Government will use this information to determine if professional employees are compensated fairly and properly. Plans indicating unrealistically low professional employees’ compensation may be assessed adversely as one of the factors considered in making a contract award. C. Annual Burden Respondents/Recordkeepers: 543,954. Total Annual Responses: 619,350. Total Burden Hours: 21,402 (21,231 reporting hours + 171 recordkeeping hours). D. Public Comment khammond on DSKJM1Z7X2PROD with NOTICES A 60-day notice was published in the Federal Register at 87 FR 1413, on January 11, 2022. No comments were received. Obtaining Copies: Requesters may obtain a copy of the information collection documents from the GSA Regulatory Secretariat Division, by calling 202–501–4755 or emailing GSARegSec@gsa.gov. Please cite OMB Control No. 9000–0066, Certain Federal Acquisition Regulation Part 22 Labor Requirements. Janet Fry, Director, Federal Acquisition Policy Division, Office of Governmentwide Acquisition Policy, Office of Acquisition Policy, Office of Governmentwide Policy. [FR Doc. 2022–05893 Filed 3–18–22; 8:45 am] BILLING CODE 6820–EP–P VerDate Sep<11>2014 21:01 Mar 18, 2022 Jkt 256001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC and the Health Resources and Services Administration (HRSA), announce the following meeting for the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSTP). This meeting is open to the public, limited only by the number of audio and web conference lines (1,000 audio and web conference lines are available). Members of the public are welcome to listen to the meeting by accessing the telephone number and web conference access provided in the addresses section below. Time will be available for public comment. DATES: The meeting will be held on April 26, 2022, from 11:00 a.m. to 5:30 p.m., EDT; April 27, 2022, from 11:00 a.m. to 4:00 p.m., EDT; and April 28, 2022, from 10:00 a.m. to 12:00 p.m., EDT. ADDRESSES: The telephone access number is 1–669–254–5252, Webinar ID: 161 660 6170, and Passcode: 77845136. The web conference access is https://cdc.zoomgov.com/j/1616606170? pwd=N0NYMkxubmxIZEl6U2N nallyNzFQQT09 and Passcode: J1G&D&Cq. There are 1,000 lines available for audio and web conference. FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–6, Atlanta, Georgia 30329–4027, Telephone: (404) 639– 3423; Email: nchhstppolicy@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This committee is charged with advising the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV, viral hepatitis, and other STDs; the support of healthcare services to persons with HIV; and education of health professionals and the public about HIV, viral hepatitis, and other STDs. Matters To Be Considered: The agenda will include discussions on (1) SUMMARY: PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 16001 Leveraging policy to advance HIV, STI, and viral hepatitis priorities; (2) Providing comprehensive STI services; (3) Syndemic approaches to HIV, viral hepatitis, and STI prevention; and (4) Self-testing and self-sample collection. Agenda items are subject to change as priorities dictate. Public Participation Procedure for Written Comment: The public is welcome to submit written comments in advance of the meeting. Written comments must be submitted in writing by email to nchhstppolicy@ cdc.gov with subject line ‘‘Spring CHAC Public Comment Registration’’ by Tuesday, April 19, 2022. Procedure for Oral Comment: Individuals who desire to make an oral statement during the public comment period may register by submitting a request in writing by email to nchhstppolicy@cdc.gov with subject line ‘‘Spring CHAC Public Comment Registration’’ by Thursday, April 21, 2022. The public comment period is on April 27, 2022, at 3:30 p.m., EDT. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–05799 Filed 3–18–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. E:\FR\FM\21MRN1.SGM 21MRN1 16002 Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices Name of Committee: Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH). Dates: June 14–15, 2022. Times: 11:00 a.m.–5:00 p.m., EDT. Place: Teleconference. Agenda: The meeting will convene to address matters related to the conduct of Study Section business and for the study section to consider safety and occupational health-related grant applications. FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, West Virginia 26506, Telephone: (304) 285– 5951; Email: mgoldcamp@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. FOR FURTHER INFORMATION CONTACT: [FR Doc. 2022–05802 Filed 3–18–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting and request for comment. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board). This meeting is open to the public, limited only by the number of audio conference lines and internet conference accesses available, which is 200 combined. The public is welcome to submit written comments in advance of khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 21:01 Mar 18, 2022 Jkt 256001 the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining a teleconference line and/or computer connection (information below). DATES: The meeting will be held on April 27, 2022, from 1:00 p.m. to 6:00 p.m., EDT, and April 28, 2022, from 1:00 p.m. to 4:00 p.m., EDT. A public comment session will be held on April 27, 2022, at 5:00 p.m., EDT, and will conclude at 6:00 p.m., EDT, or following the final call for public comment, whichever comes first. Written comments must be received on or before April 20, 2022. ADDRESSES: You may submit comments by mail to: Sherri Diana, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS C– 34, Cincinnati, Ohio 45226. Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 5252 US (San Jose); +1 646 828 7666 US (New York); +1 551 285 1373 US; +1 669 216 1590 US (San Jose); The Meeting ID is: 160 6763 3819 and the Passcode is: 98685439; Web conference by Zoom meeting connection: https:// cdc.zoomgov.com/j/16067633819? pwd=RUdiYXlZZHFK anpJOHZrcGJIbTlaZz09. Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226, Telephone: (513) 533–6800, Email: ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated PO 00000 Frm 00095 Fmt 4703 Sfmt 4703 responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The Advisory Board’s charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2020, and will terminate on March 22, 2022. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Considered: The agenda will include discussions on the following: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; SEC Petitions Update; Procedures Review Finalization/Document Approvals; Update on Review of SEC– 00253 Petition Evaluation Report for Reduction Pilot Plant; Update on Review of SEC–00188 Sandia Petition Addendum 2; Subcommittee on Dose Reconstruction Reviews Update; and a Board Work Session. Agenda items are subject to change as priorities dictate. For additional information, please contact Toll Free 1 (800) CDC–INFO. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–05800 Filed 3–18–22; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Pages 16001-16002]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05802]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463.

[[Page 16002]]

    Name of Committee: Safety and Occupational Health Study Section 
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
    Dates: June 14-15, 2022.
    Times: 11:00 a.m.-5:00 p.m., EDT.
    Place: Teleconference.
    Agenda: The meeting will convene to address matters related to the 
conduct of Study Section business and for the study section to consider 
safety and occupational health-related grant applications.

FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific 
Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, West Virginia 
26506, Telephone: (304) 285-5951; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05802 Filed 3-18-22; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.